HCP, Inc. (NYSE:HCP) has earned a consensus rating of “Hold” from the twenty-one research firms that are currently covering the firm, Marketbeat Ratings reports. Three research analysts have rated the stock with a sell rating, fifteen have issued a hold rating and three have issued a buy rating on the company. The average 12 month target price among analysts that have updated their coverage on the stock in the last year is $32.60.

Several research analysts have weighed in on the stock. BidaskClub upgraded shares of HCP from a “hold” rating to a “buy” rating in a report on Wednesday, June 21st. Royal Bank Of Canada reiterated a “hold” rating and issued a $31.00 target price on shares of HCP in a report on Wednesday, July 5th. Raymond James Financial, Inc. upgraded shares of HCP from an “underperform” rating to an “outperform” rating and set a $35.00 target price for the company in a report on Wednesday, June 14th. Zacks Investment Research lowered shares of HCP from a “hold” rating to a “sell” rating in a research report on Tuesday, July 18th. Finally, Mizuho restated a “neutral” rating on shares of HCP in a research report on Wednesday, June 28th.

HCP (HCP) traded up 0.27% on Friday, reaching $29.27. 3,230,845 shares of the company’s stock were exchanged. The firm has a market cap of $13.73 billion, a PE ratio of 19.95 and a beta of 0.37. HCP has a 12 month low of $27.61 and a 12 month high of $36.82. The firm’s 50-day moving average is $31.34 and its 200-day moving average is $31.25.

HCP (NYSE:HCP) last posted its quarterly earnings data on Tuesday, August 1st. The real estate investment trust reported $0.48 EPS for the quarter, beating the Zacks’ consensus estimate of $0.47 by $0.01. HCP had a net margin of 32.16% and a return on equity of 9.96%. The company had revenue of $458.90 million for the quarter, compared to analyst estimates of $456.29 million. During the same period in the prior year, the firm posted $0.71 EPS. The company’s quarterly revenue was down 14.8% on a year-over-year basis. On average, equities analysts forecast that HCP will post $1.36 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Tuesday, August 22nd. Shareholders of record on Monday, August 7th will be paid a $0.37 dividend. The ex-dividend date is Thursday, August 3rd. This represents a $1.48 annualized dividend and a yield of 5.06%. HCP’s payout ratio is 102.07%.

In other news, insider Thomas Klaritch sold 2,651 shares of the company’s stock in a transaction that occurred on Tuesday, June 13th. The stock was sold at an average price of $31.53, for a total transaction of $83,586.03. Following the sale, the insider now directly owns 176,830 shares of the company’s stock, valued at approximately $5,575,449.90. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. 0.22% of the stock is owned by corporate insiders.

A number of hedge funds have recently added to or reduced their stakes in HCP. Bollard Group LLC raised its stake in HCP by 21.7% in the first quarter. Bollard Group LLC now owns 41,714 shares of the real estate investment trust’s stock worth $1,305,000 after buying an additional 7,434 shares during the last quarter. Ledyard National Bank increased its position in HCP by 497.6% in the first quarter. Ledyard National Bank now owns 11,952 shares of the real estate investment trust’s stock worth $374,000 after buying an additional 9,952 shares during the last quarter. Quantitative Systematic Strategies LLC purchased a new position in HCP during the first quarter worth about $859,000. Nisa Investment Advisors LLC increased its position in HCP by 31.5% in the first quarter. Nisa Investment Advisors LLC now owns 112,761 shares of the real estate investment trust’s stock worth $3,527,000 after buying an additional 27,040 shares during the last quarter. Finally, NewSquare Capital LLC increased its position in HCP by 25.5% in the first quarter. NewSquare Capital LLC now owns 29,160 shares of the real estate investment trust’s stock worth $912,000 after buying an additional 5,921 shares during the last quarter. Institutional investors own 89.13% of the company’s stock.

ILLEGAL ACTIVITY NOTICE: This piece was originally posted by American Banking News and is owned by of American Banking News. If you are reading this piece on another publication, it was copied illegally and republished in violation of US & international copyright and trademark laws. The legal version of this piece can be read at https://www.americanbankingnews.com/2017/08/12/hcp-inc-hcp-receives-consensus-rating-of-hold-from-analysts.html.

HCP Company Profile

HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.

Analyst Recommendations for HCP (NYSE:HCP)

Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.